BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24106277)

  • 1. Identification of a receptor for neuropeptide VGF and its role in neuropathic pain.
    Chen YC; Pristerá A; Ayub M; Swanwick RS; Karu K; Hamada Y; Rice AS; Okuse K
    J Biol Chem; 2013 Nov; 288(48):34638-46. PubMed ID: 24106277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The VGF-derived peptide TLQP-21 contributes to inflammatory and nerve injury-induced hypersensitivity.
    Fairbanks CA; Peterson CD; Speltz RH; Riedl MS; Kitto KF; Dykstra JA; Braun PD; Sadahiro M; Salton SR; Vulchanova L
    Pain; 2014 Jul; 155(7):1229-1237. PubMed ID: 24657450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origins, actions and dynamic expression patterns of the neuropeptide VGF in rat peripheral and central sensory neurones following peripheral nerve injury.
    Moss A; Ingram R; Koch S; Theodorou A; Low L; Baccei M; Hathway GJ; Costigan M; Salton SR; Fitzgerald M
    Mol Pain; 2008 Dec; 4():62. PubMed ID: 19077191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VGF: a biomarker and potential target for the treatment of neuropathic pain?
    Soliman N; Okuse K; Rice ASC
    Pain Rep; 2019; 4(5):e786. PubMed ID: 31875189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.
    El Gaamouch F; Audrain M; Lin WJ; Beckmann N; Jiang C; Hariharan S; Heeger PS; Schadt EE; Gandy S; Ehrlich ME; Salton SR
    Mol Neurodegener; 2020 Jan; 15(1):4. PubMed ID: 31924226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular identity of the TLQP-21 peptide receptor.
    Sahu BS; Nguyen ME; Rodriguez P; Pallais JP; Ghosh V; Razzoli M; Sham YY; Salton SR; Bartolomucci A
    Cell Mol Life Sci; 2021 Dec; 78(23):7133-7144. PubMed ID: 34626205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling.
    Doolen S; Cook J; Riedl M; Kitto K; Kohsaka S; Honda CN; Fairbanks CA; Taylor BK; Vulchanova L
    Glia; 2017 Dec; 65(12):1976-1989. PubMed ID: 28850719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells.
    Molteni L; Rizzi L; Bresciani E; Possenti R; Petrocchi Passeri P; Ghè C; Muccioli G; Fehrentz JA; Verdié P; Martinez J; Omeljaniuk RJ; Biagini G; Binda A; Rivolta I; Locatelli V; Torsello A
    Front Pharmacol; 2017; 8():167. PubMed ID: 28424618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VGF changes during the estrous cycle: a novel endocrine role for TLQP peptides?
    Noli B; Brancia C; D'Amato F; Ferri GL; Cocco C
    PLoS One; 2014; 9(10):e108456. PubMed ID: 25280008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the VGF-derived peptide TLQP-62 in nerve injury-induced hypersensitivity and spinal neuroplasticity.
    Skorput AGJ; Zhang X; Waataja JJ; Peterson CD; Riedl MS; Kitto KF; Truong H; Huffman C; Salton SR; Fairbanks CA; Honda CN; Vulchanova L
    Pain; 2018 Sep; 159(9):1802-1813. PubMed ID: 29781959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VGF-derived peptide TLQP-21: a new modulatory peptide for inflammatory pain.
    Rizzi R; Bartolomucci A; Moles A; D'Amato F; Sacerdote P; Levi A; La Corte G; Ciotti MT; Possenti R; Pavone F
    Neurosci Lett; 2008 Aug; 441(1):129-33. PubMed ID: 18586396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the reproductive effects of the anorexigenic VGF-derived peptide TLQP-21: in vivo and in vitro studies in male rats.
    Pinilla L; Pineda R; Gaytán F; Romero M; García-Galiano D; Sánchez-Garrido MA; Ruiz-Pino F; Tena-Sempere M; Aguilar E
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E837-47. PubMed ID: 21304062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity.
    Bartolomucci A; La Corte G; Possenti R; Locatelli V; Rigamonti AE; Torsello A; Bresciani E; Bulgarelli I; Rizzi R; Pavone F; D'Amato FR; Severini C; Mignogna G; Giorgi A; Schininà ME; Elia G; Brancia C; Ferri GL; Conti R; Ciani B; Pascucci T; Dell'Omo G; Muller EE; Levi A; Moles A
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14584-9. PubMed ID: 16983076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential distribution of VGF-derived peptides in the adrenal medulla and evidence for their selective modulation.
    D'Amato F; Noli B; Brancia C; Cocco C; Flore G; Collu M; Nicolussi P; Ferri GL
    J Endocrinol; 2008 May; 197(2):359-69. PubMed ID: 18434366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLQP-21, A VGF-Derived Peptide Endowed of Endocrine and Extraendocrine Properties: Focus on In Vitro Calcium Signaling.
    Bresciani E; Possenti R; Coco S; Rizzi L; Meanti R; Molteni L; Locatelli V; Torsello A
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VGF (TLQP-62)-induced neurogenesis targets early phase neural progenitor cells in the adult hippocampus and requires glutamate and BDNF signaling.
    Thakker-Varia S; Behnke J; Doobin D; Dalal V; Thakkar K; Khadim F; Wilson E; Palmieri A; Antila H; Rantamaki T; Alder J
    Stem Cell Res; 2014 May; 12(3):762-77. PubMed ID: 24747217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells.
    Hannedouche S; Beck V; Leighton-Davies J; Beibel M; Roma G; Oakeley EJ; Lannoy V; Bernard J; Hamon J; Barbieri S; Preuss I; Lasbennes MC; Sailer AW; Suply T; Seuwen K; Parker CN; Bassilana F
    J Biol Chem; 2013 Sep; 288(38):27434-27443. PubMed ID: 23940034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing.
    Riedl MS; Braun PD; Kitto KF; Roiko SA; Anderson LB; Honda CN; Fairbanks CA; Vulchanova L
    J Neurosci; 2009 Oct; 29(42):13377-88. PubMed ID: 19846725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis.
    Cero C; Razzoli M; Han R; Sahu BS; Patricelli J; Guo Z; Zaidman NA; Miles JM; O'Grady SM; Bartolomucci A
    Mol Metab; 2017 Jan; 6(1):148-158. PubMed ID: 28123945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide TLQP-21, a VGF internal fragment, modulates hormonal gene expression and secretion in GH3 cell line.
    Petrocchi Passeri P; Biondini L; Mongiardi MP; Mordini N; Quaresima S; Frank C; Baratta M; Bartolomucci A; Levi A; Severini C; Possenti R
    Neuroendocrinology; 2013; 97(3):212-24. PubMed ID: 22699300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.